Data / Form D filings / Moonwalk Biosciences, Inc.
Moonwalk Biosciences, Inc.: Form D filings
Moonwalk Biosciences, Inc., a biotechnology company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on September 14, 2026, reports $60 million sold of a $70.2 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 TOWER PLACE, 8TH FLOOR, South San Francisco, CA, 94080
- Phone
- (650) 540-9709
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2004362
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | New notice | $70,249,973 | $59,999,998 | $10,249,975 | 7 | Aug 26, 2026 | sec.gov |
| Jan 2, 2024 | New notice | $56,824,978 | $49,574,983 | $7,249,995 | 24 | Dec 18, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alexander Aravanis | Executive Officer, Director | |
| Arash Jamshidi | Executive Officer, Director | |
| Chris Dimitropoulos | Director | |
| Paul Burton | Director | |
| Justin Valley | Executive Officer | |
| Elaine Cheung | Executive Officer | |
| Stephen Djedjos | Executive Officer | |
| John Liles | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Sep 14, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Moonwalk Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.